The relapsed cohort exhibited distinct clinical characteristics compared to the sustained remission group, including higher proportions of intermediate- or high-risk stratification, thrombocytopenia at diagnosis, and BCR::ABL1(+). This evidence concerns the gene ABL1 and Thrombocytopenia.